돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1619441생성일: 2026년 10월 26일

Cesium carbonate → 5-(4-(6-(4-(2,2-Dimethyl-1,3-dioxan-5-yl)phenoxy)-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazole

https://huagongshe.com/reaction/1619441

반응식

참여 물질

역할이름HCID투입량
반응물Cesium carbonateHCID 10796—
반응물4-(2,2-Dimethyl-1,3-dioxan-5-yl)phenolHCID 67510256—
반응물5-(4-(6-Chloro-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazoleHCID 86597366—
용매DimethylformamideHCID 6228—
생성물5-(4-(6-(4-(2,2-Dimethyl-1,3-dioxan-5-yl)phenoxy)-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazoleHCID 6751590544.9%

반응 조건

온도80 °C

반응 단계

Cesium carbonate (755 mg, 0.002317 moles) was added to a solution of 5-(4-(6-chloro-5-methylpyrimidin-4-yloxy)piperidin-1-yl)-3-isopropyl-1,2,4-oxadiazole (1.2 gm, 0.003365 moles) and 4-(2,2-dimethyl-1,3-dioxan-5-yl)phenol (700 mg, 0.003365 moles) in dry DMF (10 ml) and the reaction mixture was stirred at 80° C. for 3 hours. Then reaction mixture was poured into ice cold water and extracted with ethyl acetate. The organic extract was successively washed with water & brine, dried over sodium sulfate and concentrated under reduced pressure. The crude product so obtained was purified by column chromatography (silica gel) using 15% ethyl acetate in hexane as eluent to obtain 770 mg product as white solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08772302B2
출처 데이터셋uspto-grants-2014_07
ORD IDord-8547c1dc5c5647e9843dc3f5e033f4f9
출처 메모uspto-grants-2014_07